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ABSTRACT 
The zebrafish represents an excellent compromise between system complexity and 
practical simplicity, features that make it useful for modeling and mechanistic analysis of 
complex brain disorders. Also promising are screens for psychoactive drugs with effects 
on larval and adult zebrafish behavior. This review, based upon a recent symposium held 
at the 2016 IBNS Congress, provides different perspectives on how the zebrafish may be 
utilized to advance research into human central nervous system disorders. It starts with a 
discussion on an important bottleneck in zebrafish research, measuring the behavior of 
this species (specifically shoaling), and continues with examples on research on autism 
spectrum disorder in larval zebrafish, on screening natural products for compounds with 
psychoactive properties in adult zebrafish, and on the development of a zebrafish model 
of fetal alcohol spectrum disorders. By providing information on a broad spectrum of 
brain disorders, experimental methods, and scientific approaches using both larval and 
adult zebrafish, the review is intended to showcase this underutilized laboratory species 
for behavioral neuroscience and psychopharmacology research. 
 
Key words: alcoholism, anxiety, autism, epilepsy, fetal alcohol spectrum disorders, 
psychopharmacology, social behavior, zebrafish 
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1. Introduction 
Although a relative newcomer compared to classical biomedical laboratory research 
species including the rat or the mouse, the zebrafish is rapidly gaining popularity in a 
variety of disciplines of biology, from behavioral neuroscience (Kalueff et al., 2014; 
Sison et al., 2006) to genetics (Patton & Zon, 2001).  The first zebrafish study, according 
to ISI Web of Science was published in 1954 (Battle & Mcleese, 1954).  The very first 
study on record in the PubMed database that used zebrafish with a biomedical focus was 
published in 1957 (Hisaoka & Hopper, 1957), and for the next three decades, the number 
of publications using zebrafish remained low but increasing steadily from a couple of 
papers to a handful of papers per year. However, since the early nineties, this increase 
accelerated, jumping from tens of papers to nearly 3000 yearly publications on zebrafish 
by 2016.  Notably, although still orders of magnitude fewer than the number papers on 
the mouse or the rat, the increase of the number of publications on zebrafish significantly 
outpaced those on the latter two species (Kalueff et al., 2014).  
The reason for the increasing popularity of the zebrafish is that it represents an 
excellent compromise between system complexity and practical simplicity. It is a 
vertebrate complex enough to allow sufficient translational relevance (Gerlai, 2014). 
Most importantly, the nucleotide sequence of its genes has been found to be similar to 
that of human homologs, often reaching or exceeding 70% homology (Howe et al., 
2013). This high degree of genetic conservation strongly suggests that when genes are 
found to serve specific functions in zebrafish, similar genes will be involved in the same 
function in humans.  Screening a large number of mutant zebrafish, however, is a lot 
simpler, and most importantly, a substantially cheaper exercise than doing the same with 
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laboratory mammals such as the mouse or the rat. For example, several studies utilize 
larval zebrafish, i.e. zebrafish that are about 5-10 post-fertilization day old.  At this size 
(around 1mm total length) zebrafish is already freely swimming, and exhibits a fairly 
complex behavioral repertoire and responds to a variety of stimuli of all possible 
modalities.  At this size, the behavioral responses may be quantified using 96 well plates.  
Numerous commercially available zebrafish movement analysis and stimulus delivery 
systems have been developed which utilize the 96 well plate set up and thus can measure 
a large number of fish very quickly.  Most behavioral paradigms require no more than 10 
min of session length, thus in an 8-hour day, one can obtain detailed video-tracking-based 
movement analysis data on over 4600 fish, just using a single 96 well plate system.  This 
throughput is about two orders of magnitude faster than what is usually achieved in 
rodent behavioral screening studies (Gerlai, 2014b; 2010; 2002).  Adult zebrafish require 
more space than larval ones do, but usually even adult fish can be tested much faster than 
rodents.  Numerous behavioral paradigms have been developed for adult zebrafish that 
allow one to screen hundreds of fish per day even with a single behavioral set up (Gerlai, 
2014b; 2010).  Also, notably, the zebrafish represents good reduction and refinement 
from an animal ethics perspective, as it is a simpler vertebrate compared to mammalian 
laboratory species.  Last, the zebrafish is a vertebrate, and thus is substantially more 
complex and evolutionarily closer to humans than drosophila or the nematode, two of the 
most frequently employed non-vertebrate model organisms in genetics and neuroscience. 
In summary, the zebrafish appears to strike an optimal compromise between system 
complexity and practical simplicity, sophistication and test throughput, and as a result has 
become one of the primary tools for forward as well as reverse genetic studies 
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(Amsterdam and Hopkins, 2006; Chen and Ekker, 2004; Lekven et al., 2000; Patton and 
Zon, 2001). These studies focused on phenotypes relevant for developmental biology. 
More recently, however, the zebrafish has been rediscovered for many other domains of 
investigations, behavioral neuroscience and psychopharmacology being among them 
(Stewart et al, 2014; Kalueff et al., 2014; Gerlai, 2012).   
The zebrafish has been found to possess evolutionarily conserved features at many 
levels of its biological organization, not just at the level of genetics. For example, it has a 
typical vertebrate brain that shares its basic neuroanatomical layout with that of other 
vertebrate species (Tropepe and Sive, 2003), and its neurotransmitter systems are also 
similar to those of mammals (Chatterjee and Gerlai, 2009). For the latter reason, and not 
surprisingly, drugs developed for human clinical applications, or for other mammalian 
species, have often been found efficacious in zebrafish acting through similar if not 
identical receptors and biochemical mechanisms compared to those of mammals (Kalueff 
et al., 2014; Levin et al., 2015). For these reasons, the zebrafish has been suggested as an 
appropriate laboratory tool for the screening of not only mutations but also drugs and 
compounds. Given the huge number of compounds developed in pharmaceutical research 
by companies and academic laboratories alike, the need for an efficient screening tool is 
clear.   
This need is further emphasized by the staggering number of human brain disorders 
for which pharmacotherapy has been insufficient or unavailable (e.g. Klafki et al., 2006; 
Poewe, 2009; Shelton et al., 2010). Furthermore, the brain is perhaps the most complex 
organ, and thus the mechanisms of its dysfunctions are often not well understood. In 
short, the brain is considered one of the final frontiers of biology, and brain disorders 
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continue to represent a substantial unmet medical need. To alleviate these problems and 
to meet this need, animal models with sufficient translational relevance have been 
suggested for a broad range of human brain disorders and/or for neurobiological 
mechanisms suspected to be involved in such disorders (Stewart et al., 2014, 2015a; 
Kalueff et al., 2014; Gerlai, 2010, 2012). The zebrafish may be not only a translationally 
relevant tool for such studies, but it may also represent one of the most efficient and 
cheapest approaches. It is a small (4 cm long) animal that can be housed in large numbers 
cost effectively. It is also highly prolific with a single adult female being able to produce 
2-300 eggs 2-3 times per week. Zebrafish phenotyping can be highly automated, which 
not only allows for repeatable measurements in many animals, but also enables longer-
term behavioral observations that may identify phenotypes that may be missed in short-
term observations. Although there are many similarities between the zebrafish and 
mammalian species, given that the zebrafish is evolutionarily older, its brain is 
substantially less complex than the mammalian brain, a feature that has been argued to 
enable one to discover the more fundamental, core, and thus most important mechanisms 
relevant to the biological phenomenon, or disease, under study (Gerlai, 2014). Thus, the 
zebrafish should be an excellent drug screening tool.  Screening for psychoactive or other 
brain function altering compounds using the zebrafish, however, may be hindered by 
numerous factors. First and foremost, appropriate screening methods such as specific 
behavioral test paradigms are often unavailable for the zebrafish, a species that is a 
relative newcomer in psychopharmacology. Furthermore, information about drug 
absorption, distribution, metabolism and excretion (ADME) of compounds is often 
unavailable in either larval or adult zebrafish.   
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This review presents diverse aspects of this novel but rapidly evolving field, 
zebrafish neuropsychopharmacology. Although this review is far from comprehensive, its 
topics are chosen to cover a broad spectrum of questions and areas of investigation with 
zebrafish. It is a sampling of fairly different research areas and methods as well as disease 
foci, including autism spectrum disorders (ASDs), anxiety, and embryonic alcohol 
exposure induced problems. The review covers questions related to designing behavioral 
paradigms for testing drug effects and identifying potentially interesting efficacious 
compounds and also present examples on how to combine methods and approaches of 
psychology, ethology, pharmacology, genetics and neurobiology. In summary, this 
review attempts to showcase the zebrafish as a promising laboratory research organism 
for psychopharmacology, neurobiology and behavior genetics, while pointing out both 
the advantages and the current shortcomings of this species in empirical research. 
 
2. Social behavior of the zebrafish: Why and how should we measure it? 
The relative paucity of appropriate behavioral test paradigms and our limited 
understanding of the behavior of the zebrafish (Sison et al., 2006) represent important 
bottlenecks in behavioral genetic, behavioral neuroscience and psychopharmacological 
analysis of the zebrafish.  Recognizing this problem, the past decade has seen a dramatic 
upsurge of studies focused on zebrafish behavior (Kalueff et al., 2014).  Social behavior 
of the zebrafish has started to be characterized too. The following section focuses on a 
specific form of zebrafish social behavior, shoaling.  Shoaling may easily be induced and 
precisely quantified using juvenile and adult zebrafish in the laboratory, and more 
importantly, its analysis may have important translational relevance. 
Zebrafish models of human brain disorders 8 Shams et al. 
 
 
2.1 Human disorders with abnormal social behavior as a core symptom 
According to the Diagnostic and Statistical Manual of Mental Disorders (5th ed.; 
DSM-5; American Psychiatric Association, 2013), abnormal social interaction is a core 
symptom for many different classes of disorders, but some argue that almost all human 
neurological and psychiatric disorders disrupt certain aspects of social function to a 
degree (Henry et al., 2016). Diseases that affect social interaction include ASD and the 
Fetal Alcohol Syndrome Disorders (FASD), which affect development of age appropriate 
communication and social skills (American Psychiatric Association, 2013).  
Schizophrenia and other psychotic disorders, that alter cognitive processing, can also lead 
to social abnormalities, while mood and anxiety disorders such as depression or social 
anxiety disorders can limit social interaction (American Psychiatric Association, 2013). 
Personality disorders including sociopathy and psychopathy, disruptive and impulsive 
disorders (antisocial personality disorder and conduct disorder), and even substance 
abuse and addiction may lead to reduced affective control, increased social aggression 
and/or impaired social perception (American Psychiatric Association, 2013). Even such 
neurodegenerative disorders as age-related dementia, Parkinson’s disease, and 
Alzheimer’s disease may result in social behavior abnormalities related to emotional or 
motivational issues (American Psychiatric Association, 2013; Henry et al., 2016; Jones 
and Norton, 2015). Given the complexity of the above disorders and the importance of 
social behavior in our species, and given our limited understanding of the biology of this 
behavior, developing models of abnormal social interaction in social animals is an 
essential enterprise.  The zebrafish has been suggested as a promising model for a variety 
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of human CNS disorders and has been used across multiple disciplines as a tool to study 
human disorders with social abnormalities (Morris, 2009; Norton, 2013; Stewart et al., 
2014; Tropepe and Sive, 2003). The complexity of zebrafish social behavior 
complements this species’ practical advantages.  It allows the induction and modeling of 
a potentially wide range of social abnormalities and a spectrum of severity of symptoms, 
a particularly useful feature of the zebrafish for modeling human disorders across the 
spectra of symptoms and severity. Implementing these models will require a better 
understanding of zebrafish social behavior and of the neural mechanisms that underlie it. 
 
2.2 Social behavior of zebrafish 
Characterization of social behavior of the zebrafish (Dahlbom et al., 2012; Miller 
and Gerlai, 2007) and specific features of social interaction (Qin et al., 2014; Saverino 
and Gerlai, 2008) have already begun. A typical feature of zebrafish social interaction is 
shoaling, the tendency to form and remain in a tight group (Miller and Gerlai, 2007). 
Shoaling is distinguished from schooling, the latter being associated with coordinated 
swimming direction, while the former simply represents the aggregation of individuals 
without synchronization of movement (Miller & Gerlai, 2012). Both these forms of group 
forming behaviors have been observed, albeit under different circumstances, in adult 
zebrafish (Miller & Gerlai, 2012). For example, shoaling tends to dominate in habituated 
fish, whereas schooling appears under aversive conditions or in response to a clear and 
present danger (Miller & Gerlai, 2012). Although innate, shoaling is not observed in 
zebrafish younger than 7 days post-fertilization (dpf). But as the fish mature, shoaling 
appears (demonstrated by 15 dpf ), and cohesion among shoal members significantly 
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increases until the fish reach sexual maturity at age 3-4 months, after which shoaling 
plateaus (Buske and Gerlai, 2011; Dreosti et al, 2015; Hinz & de Polaveija, 2017).  
Shoaling may have negative consequences, for example, increased competition, 
aggressive encounters with shoal mates, and stress for subordinate fish due to social 
hierarchy (Gómez-Laplaza and Gerlai, 2011; Pavlidis et al., 2011).  Nevertheless, 
adaptive advantages, including protection from predators, effective identification of food 
patches, and access to mates (Miller and Gerlai, 2007; Spence et al., 2008), appear to 
outweigh the disadvantages. 
Besides shoaling, other social behavioral phenomena such as establishment of 
dominance hierarchy (Dahlbom et al., 2012; Larson et al., 2006), aggression (Teles and 
Oliveira, 2016; Way et al., 2015), courtship and reproductive behaviors have also been 
investigated in zebrafish (Coe et al., 2010; Ruhl et al., 2009). Similarly, there has also 
been a growing interest in characterizing non-social behaviors of zebrafish that may be 
related to social interaction and may allow better modeling of various human disorders 
(Seguin et al., 2016). Non-social behaviors that may influence social responses include 
locomotion, learning, anxiety, and fear responses (Al-Imari and Gerlai, 2008; Bencan et 
al., 2009; Lee et al., 2010; Maximino et al., 2010; Saili et al., 2012), but how these factors 
may influence social responses and how they may be regulated by social context remain 
unexplored.  
While strain differences demonstrating the effects of genes on shoaling have been 
documented (Barba-Escobedo and Gould, 2012; Mahabir et al., 2013; Wright et al., 
2003), no specific genes or quantitative trait loci associated with shoaling have been 
identified (Miller and Gerlai, 2007; 2011b). Similarly, while changes in the levels of 
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neurotransmitters such as dopamine and serotonin have been found to be positively 
correlated with shoaling in zebrafish (Buske and Gerlai, 2011; Dahlbom et al., 2012; Saif 
et al., 2013; Shams et al., 2015), specific functional mechanisms and brain regions that 
control shoaling remain poorly understood. Nonetheless, reliable paradigms that allow 
manipulation and quantification of shoaling and related behaviors provide unique 
opportunities to predict, test, and understand biological mechanisms that regulate 
shoaling and, in turn, enhance social behavior research. 
 
2.3 How to induce and measure shoaling in zebrafish 
Shoaling is a robust social behavior typical of zebrafish that is readily observable 
in the wild (Spence et al., 2008; Suriyampola et al., 2016) and easily elicited in a 
laboratory setting by providing suitable social stimuli (Qin et al., 2014). For example, the 
existence or strength of shoaling may be tested using a choice task in which the test fish 
is placed singly in the middle of an aquarium flanked on opposite sides by social or 
control stimuli (Miller and Gerlai, 2007). The social stimulus can be a group of live 
conspecific fish, computer-animated images of zebrafish, or small robotic probes that 
physically emulate zebrafish (Abaid et al., 2012; Butail et al., 2014; Saverino and Gerlai, 
2008), while the control may be an empty aquarium, a blank screen, or objects or images 
not resembling fish. The experimenter can make video recordings from the front of the 
tank (side-view) and analyze the recordings to quantify preference using various 
commercially available automated tracking programs or manual as well as computer 
aided event recorders. Tracking software applications can monitor movement of the test 
fish, record x-y coordinates, and extract several swim path parameters, including time 
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spent in proximity of the visual stimuli or distance from the stimulus side vs. the control 
side. These preference or choice tasks may also be utilized to investigate the effect of 
numerous aspects of the social stimulus, including shape, color, pattern, movements, 
location, number, density of the stimulus images.  
On the other hand, more natural group dynamics can be investigated by placing 
multiple experimental fish (usually 4-10) together in an open-tank where they can freely 
move.  In a freely moving shoal not only visual but also olfactory, auditory, and lateral 
line related information may be perceived by shoal members, and the behavior of the 
target fish may be influenced by the interaction between all members of the shoal 
(Engeszer et al., 2004). In this set up, the movements of the experimental fish are usually 
monitored from an overhang camera (bird’s-eye view), which allows recording of 
numerous dynamic aspects of shoaling behavior (Buske and Gerlai, 2014). Behavioral 
parameters one may extract include the area occupied by the whole group, inter-
individual distances, nearest-neighbor distances, polarization of movement, excursions or 
fissures from the group (Buske and Gerlai, 2011; Miller and Gerlai, 2007; 2008; 2011a. 
2011b; 2012; Miller et al., 2013; Shams et al., 2015). While lacking experimental control 
of the stimuli perceived (increased variability) and posing a greater challenge of the 
quantification of behavior (i.e., a larger number of dynamically moving agents to track 
and statistically analyze), the analysis of freely moving live shoals allows more precise 
description of the dynamic social responses of the zebrafish both in short (seconds) and 
longer (days, weeks or months) time scales (Miller and Gerlai, 2008; Buske and Gerlai, 
2011). Both the monitoring of live shoals and the application of computerized social cues 
as animated images of conspecifics may be utilized to investigate changes of social 
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behavior induced by a variety of experimental manipulations, including the delivery of 
different environmental stimuli (Engeszer et al., 2004; Gerlach et al., 2008; Moretz et al., 
2007) or pharmacological agents (Coe et al., 2010; Buske and Gerlai, 2010).  
 
2.4 The effect of environmental stimuli on shoaling 
Interestingly, abiotic as well as biotic environmental factors can enhance or 
dampen social interaction. Abiotic factors such as substrate of home/testing tanks, speed 
of water flow, and presence of vegetation can affect social interaction, particularly 
aggressive and reproductive behaviors (Keck et al., 2015; Suriyampola et al., 2016). 
Presence of predators can influence shoal cohesion, while presence of social stimuli can 
affect anxiety and fear responses (Schaefer et al., 2015). The size and composition of the 
stimulus shoal are also important, and several features of shoal mates have been shown to 
also induce preferential responses in zebrafish, including sex and number of shoal 
members shown, sex ratio within the stimulus shoal, body size, stripe pattern, and 
pigmentation of stimulus fish (Kitevsky and Pyron, 2003; Ruhl and McRobert, 2005; Qin 
et al., 2014; Seguin & Gerlai, 2017; Seguin et al., unpublished results). 
Manipulation of the early social environment such as composition of the social 
rearing group and exposure to specific pigment or stripe pattern phenotypes can result in 
changes in subsequent social behavior and shoaling preference (Engeszer et al., 2004; 
Moretz et al., 2007). The absence of specific visual or odor cues from siblings for the first 
seven days of life has been shown to result in the reduction or loss of future kin 
recognition, while complete social isolation across development has been found to impair 
social behavior later in life (Engeszer et al., 2004; Gerlach et al., 2008). However, the 
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effect of complete isolation has not been investigated past the larval stage, and thus we do 
not yet know whether effects may persist in adulthood.  
In contrast, the effects of isolation of adult zebrafish have been relatively well 
studied.  Isolation of adults prior to or during experimental manipulation is often 
employed as it allows the experimenter to individually recognize, monitoring, or 
manipulate the subjects across multiple occasions or trials (Al-Imari and Gerlai 2008; 
Teles et al., 2013). Although not specifically designed to analyze the effects of isolation 
per se, the isolation procedure may lead to numerous changes in social and non-social 
behaviors. Long social deprivation in adulthood (90 days) have been found to alter 
anxiety-related responses and to reduce whole-brain serotonin and whole-body cortisol 
levels in adult zebrafish (Shams et al., 2015). Behavioral paradigms, in particular social 
interaction tasks and tests of anxiety and locomotor activity, may be unreliable if prior 
social experience and social environment of the testing or stimulus fish are not taken into 
consideration. Underlying functional mechanisms such as specific brain areas and 
neurotransmitter systems that may be affected by acute, chronic, and developmental 
social isolation must be thoroughly investigated in the future.  
 
2.5 The effects of pharmacological agents on shoaling 
The zebrafish has been utilized for the screening and the analysis of the effects of 
several toxicants, teratogens, environmental pollutants and other pharmacologically 
active compounds. For example, exposure to pentylenetetrazol, valproic acid, or ethanol 
during early development has been shown to significantly affect subsequent development 
and expression of behavioral and physiological characteristics (Cowden et al., 2012; Lee 
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et al., 2010; Zellner et al., 2011). Additionally, embryonic exposure to low doses of 
alcohol has been found to result in impaired shoaling, as well as abnormal functioning of 
the dopaminergic neurotransmitter system in adulthood (Buske and Gerlai, 2011; 
Fernandes and Gerlai, 2009; Fernandes et al., 2015b). Similarly, early transient exposure 
to synthetic estrogen (Ethinylestradiol) has been shown to affect adult breeding behavior 
and reproductive success (Coe et al., 2010).  
The effects of anxiolytics, antidepressants and psychostimulants on the behavior 
of adult zebrafish have also been investigated (see Shams and Gerlai, 2016, for a review) 
but opioids and cannabinoids remain understudied (Gebauer et al., 2011). For instance, 
exposure to anxiolytics (fluoxetine, buspirone, or diazepam) leads to impaired shoaling 
(Giacomini et al., 2016). Shoaling may also be disrupted by lower doses of selective 
serotonin reuptake inhibitors (SSRIs) and other antidepressant drugs, but higher doses 
have been found to enhance social interaction in zebrafish (Schaefer et al., 2015). 
NMDA-receptor antagonism with MK801 has been found to induce social deficits, which 
can be reversed by certain antipsychotics (e.g. sulpiride) but not by others (e.g. 
haloperidol) (Savio et al., 2012). Acute nicotine treatment was found to reduce shoal 
cohesion, while chronic nicotine was found to slightly increase shoaling (Miller et al., 
2013; Stewart et al., 2015b). Overall, these findings suggest that shoaling behavior is 
highly responsive to a large number of pharmacological agents as well as environmental 
manipulations.  Although promising, these lines of research may be viewed only as 
pioneering with effects and mechanisms that are often not yet understood.  
 
2.6 Prospects for shoaling analysis to model human disorders 
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Shoaling behavior in zebrafish can be a powerful tool that may permit modeling 
of social abnormalities found in various human disorders, even ones exhibiting varying 
degree of severity in symptoms and co-morbidities (Jones and Norton, 2015). Although 
not a comprehensive account of the literature on manipulation and measurement of 
shoaling in zebrafish, the reviewed studies hopefully demonstrate the utility of the 
zebrafish in general and the usefulness of measuring shoaling responses in particular. It 
should also be clear that we have significant gaps in our understanding of both the 
biological and the behavioral mechanisms of shoaling. Thus, the question remains open 
whether shoaling behavior meets the three criteria of a good animal model, namely face, 
construct and predictive validity.  Nevertheless, given the powerful genetic and 
neurobiological tools developed for the zebrafish, and given the increasingly 
sophisticated methods custom designed for the analysis of its behavior, we hope that the 
above question will soon be answered in an affirmative manner.   
One of the human diseases for which the zebrafish has been suggested as an 
excellent model (Tropepe & Sive, 2003) and for which proper analysis of shoaling in 
zebrafish may be highly important is the ASD cluster, diseases characterized by abnormal 
social behavior.  The following section reviews the use of zebrafish in modeling ASD. 
 
3. Behavioral, anatomical, and pharmacological phenotyping of zebrafish models of 
ASD 
3.1 What is ASD? Symptoms, prevalence and treatment options  
ASD are a group of neurodevelopmental conditions characterized by deficits in 
social interaction, poor communication, and repetitive behaviors or restricted interests 
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(American Psychiatric Association, 2013). Although estimates vary, roughly 1% of 
children worldwide are born with some form of ASD (Lai et al., 2014) and upwards of 1 
in 68 children are diagnosed with ASD (Christensen et al., 2016). ASD are 
phenotypically heterogeneous, and patients can suffer not only from a wide range of 
severity in the core symptoms of social interaction and repetitive behaviors, but also may 
present with a variety of co-morbidities, including sensory sensitivity, motor function 
impairment, intellectual disability, gastrointestinal distress, sleep disruption, and epilepsy 
(Geschwind, 2009). ASD are highly heritable, and alterations in many genetic loci have 
been now been linked to ASD through analysis of copy number variants (CNVs), 
genome-wide association studies, and whole exome sequencing efforts (De Rubeis et al., 
2014; Iossifov et al., 2014; Krishnan et al., 2016; Poelmans et al., 2013; Sanders et al., 
2011). 
The Simons Foundation Autism Research Initiative (SFARI) Gene Database, as 
of Sept 2016, lists 845 genes that have been linked to ASD, with roughly 65 genes and a 
handful of copy number variants (i.e. large stretches of duplicated or deleted DNA 
sequences that can even encompass many genes) considered to be high confidence ASD 
risk loci. Although network analyses of gene function and spatial-temporal co-expression 
have hinted at core ASD signaling pathways (Ellegood et al., 2015; Parikshak et al., 
2013; Voineagu et al., 2011; Willsey et al., 2013), the genotypic and phenotypic diversity 
of ASD pose considerable challenges in identifying common underlying mechanisms, 
which in turn impede the search for effective treatments. Indeed, what is more notable in 
comparative analyses across 10-25 rodent ASD models is the observed phenotypic 
diversity rather than the areas of overlap (Ellegood et al., 2015; Ey et al, 2011). What is 
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needed are good animal models for ASD in which these basic questions can be tackled. 
However, given the genetic diversity of ASD, the development of an appropriate set of 
animal models that can capture the phenotypic diversity of ASD is difficult, likely 
requiring a cross-comparative approach among a set of animals harboring mutations in 
the many ASD risk genes.  
 
3.2 Unique advantages of zebrafish in ASD modeling 
In light of the specific challenges involved in modelling complex, multi-genic 
disorders, especially the need to cost-effectively produce and phenotype dozens of 
genetic models that encompass the range of ASD phenotypes, the zebrafish model has 
several attractive features.. In particular, zebrafish at their larval stages are optically 
transparent and develop externally, allowing for the direct visualization of morphological 
changes during early development (Tropepe & Sive, 2003). Brain development is rapid, 
as the larval zebrafish goes from a single fertilized cell to an embryo with fully 
established body axes and an embryonic brain with distinct vertebrate morphology and 
anatomical subdivisions by 28 hours post fertilization (hpf) (Kimmel et al., 1995). Within 
5 dpf, major neurotransmitter and peptidergic neuronal subtypes are in place and the 
larvae are capable of complex behaviors (Panula et al., 2010). The larval brain is small 
enough to also allow whole mount antibody staining and imaging for a global 
visualization of the formation of major axon tracts, proper patterning of neuropil, and the 
development of major neurotransmitter classes (Turner et al., 2014; Wilson et al., 1990). 
The differentiation, migration, and morphological characteristics of many cells can be 
readily tracked in vivo with an increasing collection of zebrafish driver lines that express 
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fluorescent proteins (e.g. green fluorescent protein, GFP) in cells of interest (Kawakami 
et al., 2016). Many transgenic lines are available that label neurons with particular 
relevance to ASD, such as inhibitory GABAergic interneurons (Zerucha et al., 2000) or 
neurons that express the neuropeptide, oxytocin (Blechman et al., 2011), which is thought 
to regulate social interaction in many species (Peñagarikano, 2016). Time lapse movies of 
intact animals over several days can visualize the differentiation and migration of neurons 
(Satou et al., 2013), the projection of axons and dendrites and the formation and 
destruction of synapses (Appelbaum et al., 2010; Shamay-Ramot et al., 2015), all 
processes whose dysfunction have been implicated in ASD. Furthermore, transgenic 
driver lines can be used to manipulate neurons for interrogation of neuronal function, for 
example, to visualize neuronal activity using genetically encoded calcium indicators 
(Ahrens et al., 2012), to ablate neurons with cell-specific toxins or lasers (Mathias et al., 
2014; Roeser and Baier, 2003), or to activate or inhibit neurons with small molecules (i.e. 
chemogenetics) or with light (i.e. optogenetics) (Chen et al., 2016; Portugues et al., 
2013). “Snapshots” of whole brain activity can also be taken using in situ hybridization 
of the immediate early gene c-fos, a marker of neuronal activity (Ellis et al., 2012), or 
with antibody staining for another activity marker, phosphorylated ERK (Randlett et al., 
2015). Together, this collection of tools for the interrogation of neural development and 
function will enable in vivo dissection of the changes that occur when ASD risk genes are 
mutated.  
Another attractive feature of the zebrafish model is the rich repertoire of 
behaviors that appear at early developmental ages. At 24 hpf, larvae are already capable 
of simple behaviors, such as coiling in response to touch (Saint-Amant and Drapeau, 
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1998). By 3 dpf, the retina is wired to respond to visual stimuli (Fadool and Dowling, 
2008), and the larvae can spontaneously swim. By 5 dpf, the larvae are free swimming 
and exhibit complex behaviors that integrate internal and external stimuli across multiple 
sensory modalities, such as hunting (Budick and O’Malley, 2000), motor learning 
(Kawashima et al., 2016), and sleep (Zhdanova et al., 2001). Many of the major 
behavioral co-morbidities with relevance to ASD, including sleep-wake disturbances, 
seizures, and gastrointestinal problems (Geschwind, 2009), can be studied in these early 
larval stages. Using a high speed camera, detailed kinematic analysis of larval 
spontaneous and visually-evoked motor responses can detect alterations in muscle 
coordination, inter-bout intervals, swim speed, and other parameters (Fontaine et al., 
2008; Severi et al., 2014). Sensory sensitivity can be measured by examining 
sensorimotor gating and habituation of startle responses to acoustic (Burgess and 
Granato, 2007; Wolman et al., 2011) or visual (Emran et al., 2007) stimuli. Long term 
behavioral tracking over several days can identify changes in sleep bout patterns across 
the 24-hour day-night cycle (Rihel et al., 2010). Spontaneous and drug-induced seizures 
(e.g. by exposing larvae to the GABA-receptor antagonist, Pentylenetetrazol, PTZ) can 
be observed using both behavioral and electrophysiological criteria (Baraban et al., 
2005). Non-behavioral perturbations can also be investigated; for example, gut function 
can be elegantly tracked in zebrafish by feeding the larvae fluorescent material and 
measuring transit time (Field et al., 2009). Importantly, for most of these behavioral 
assays, dozens or hundreds, even thousands of larvae can be simultaneously measured, 
which facilities drug screening via direct application of small molecules into the larval 
home-tank water (Rihel and Schier, 2012).  
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Zebrafish are also highly social animals, showing a clear preference for 
conspecifics in a simple T-maze by three weeks of age (Dreosti et al., 2015).  The first 
significant signs of shoaling (group forming) have been demonstrated by the age of 15 
dpf (Buske & Gerlai, 2011; Dreosti et al, 2015; Hinz & de Polaveija, 2017), and 
sophisticated and complex social interactions have been already described (see section 
above). Although obviously of great interest for the study of ASD, it is not yet clear to 
what extent the circuits, and the neurobiological mechanisms in general, that control 
social behavior in zebrafish are conserved across fish and mammals, including humans. 
Nevertheless, linking social interaction to discrete circuits that are perturbed by mutations 
in ASD risk genes would be a promising future avenue of research. 
 
3.3 Genetics of ASD in zebrafish  
Most human ASD-risk genes have been found conserved in the zebrafish. From 
genome searches, we estimate >90% of human ASD genes have a clear ortholog in 
zebrafish (Rihel, personal observation; also see Tropepe & Sive, 2003; McCammon & 
Sive, 2015; Wright & Washbourne, 2011).  To date, most of the zebrafish studies of 
ASD-associated genes have employed a knockdown approach using morpholinos (MOs), 
which are anti-sense oligonucleotide-like molecules with a specialized backbone that can 
block either translation or splicing of targeted transcripts-of-interest when injected into 
the zebrafish embryo (Nasevicius and Ekker, 2000). Typically, these studies have focused 
on alterations in early neuronal development following MO injection, with a few studies 
also examining effects on sensory-evoked locomotor behavior and seizures. For example, 
MO knockdown of the ASD gene met (a tyrosine kinase receptor) led to reduced cell 
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proliferation in the cerebellum (Elsen et al., 2009), knockdowns of either zebrafish 
shank1a, shank1b, or syngap1b delayed brain development and caused seizures and 
altered motility (Gauthier et al., 2010; Kozol et al., 2015), and MOs targeting autism 
susceptibility candidate 2 (auts2) led to reduced head size and loss of neurons 
(Oksenberg et al., 2013). Other zebrafish knockdown studies focused particularly on head 
size, which is often altered in ASD patients, including targeted knockdowns of kcdt13 
(Golzio et al., 2012) and chd8 (Bernier et al., 2014; Sugathan et al., 2014), which caused 
macrocephaly. In light of concerns that MO injections cause unwanted and poorly 
understood side effects, which often include alterations to head size, neuronal 
development, and perturbations of motor neuron function, most zebrafish studies of ASD 
using MOs should now be interpreted with great caution (Lawson, 2016). Systematic 
comparison of mutant and morphant data demonstrated that MOs often fail to recapitulate 
genetic loss of function mutant phenotypes, suggesting that MOs are causing non-specific 
phenotypes (Kok et al., 2015, although see Rossi et al., 2015 for other specific 
possibilities). When evaluating ASD morphant phenotypes, it is helpful to keep in mind 
the published criteria for analysis of MOs (Eisen and Smith, 2008), including 1) 
phenotypic rescue by co-injecting mRNA, 2) using two independent MOs targeting the 
same gene, and 3) confirmation by comparison to a mutant in the same gene. Perhaps the 
tendency of ASD-risk genes to be unusually large in both humans and zebrafish (King et 
al., 2013; Kozol et al., 2016) has precluded easy demonstration of morphant rescue with 
functional mRNA, but this only emphasizes the need for confirmation of morphant ASD 
phenotypes with genetic mutations.  
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Going forward, the availability and ease of modern gene editing techniques will 
become the gold standard for the analysis of ASD gene function in zebrafish. However, 
editing ASD genes in zebrafish poses its own challenges. Many of the large ASD genes 
undergo complex alternative splicing, so mutants must be carefully evaluated for true loss 
of function. Intriguingly, some 50-60% of ASD genes are duplicated in zebrafish 
(compared to roughly 20% across the mammalian genome), which may require the 
targeting of each copy to create a loss of function ASD gene model (Kozol et al., 2016).  
Nevertheless, often the expression of these duplications are restricted to non-overlapping 
tissues or take on separated functions, thereby affording the opportunity to dissect genes 
with pleiotropic functions (Conant and Wolfe, 2008). In any case, the advent of the 
powerful and straightforward Crispr/Cas9 gene editing technology, which can be 
multiplexed to simultaneously generate mutant alleles in the same animal, makes 
functional gene redundancy a more easily tackled problem in zebrafish (Jao et al., 2013).  
The few zebrafish mutants in ASD risk genes generated to date point to alterations in 
excitatory-inhibitory balance. For example, null mutants for the Rett Syndrome gene, 
mecp2, have defects in spontaneous swimming bouts (Pietri et al., 2013), while mutants 
that lack both zebrafish orthologs of the ASD risk gene contactin associated protein-like 
2 (cntnap2) have a large reduction in GABAergic interneurons, seizure susceptibility, and 
behavioral hyperactivity at night (Hoffman et al., 2016). These conclusions are broadly 
consistent with rodent models harboring mutations in MeCP2 and CNTNAP2. For 
example, several MeCP2 mutant lines have been generated that have motor defects and 
lowered cortical activity due to alterations in excitatory-inhibitory balance (e.g. Dani et 
al., 2005). As in the zebrafish, CNTNAP2 mouse mutants have epilepsy, a loss of 
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migrating GABAergic interneurons, and hyperlocomotor activity in an open field test 
(Penagarikano et al., 2011). While these zebrafish ASD mutant examples are consistent 
with phenotypes in both humans and rodent models, these mutant phenotypes are 
generally much milder than observed in morphant studies, further underscoring the 
importance of testing gene function with mutational analysis. How well zebrafish models 
of other ASD risk genes will concord with rodent studies remains an open question until 
the relevant mutants are generated and tested. Importantly, the extent to which zebrafish 
ASD mutants will exhibit alterations in social and repetitive behaviors remains unknown.  
 
3.4 Integration of imaging, behavior, genetics, circuits, and drugs 
The power of the larval zebrafish model will rely on the ability to rapidly identify 
how genetic lesions in ASD risk genes alter the development of neuronal circuits that 
modulate ASD-associated behaviors and then to leverage small molecule screens to find 
drugs that can revert mutant phenotypes. An example of such an approach is the recent 
study of the zebrafish cntnap2 mutants by Hoffman et al. (2016). By comparing the 
nighttime hyperactive phenotype of cntnap2 mutants to behaviors induced in wild larvae 
exposed to a large panel of small molecules, they were able not only to predict NMDA 
receptor antagonists as potent sensitizers of the mutant behavior, but they also discovered 
that estrogenic compounds, including the phytoestrogen biochaninA, selectively rescued 
the phenotype. This kind of “predictive pharmacology” offers the potential to avoid labor 
intensive drug screening on mutant backgrounds by first preselecting promising candidate 
compounds for a more targeted search.  
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The analysis of cntnap2 mutants also established a core set of ASD related 
phenotypes that span neuronal development (i.e. whole brain imaging of GABAergic 
interneurons and other cell types), seizure propensity, sleep, and drug sensitivities 
(Hoffman et al., 2016). As more zebrafish mutants are generated for the many other ASD 
genes, it will be of great interest to determine the degree of overlap and divergence 
observed among these phenotypes across the various genetic lesions. How much of the 
variation among ASD mutants will converge on the same brain structures, the same 
circuits, and the same drugs? Another major open question is the extent to which 
phenotypic diversity among zebrafish ASD models will predictively overlap with the 
diversity of phenotypes in human patients. Might the animal models suggest phenotypic 
groupings among risk genes that can help to further subdivide the spectrum of autistic 
patients into distinct classes? The answer to this question may have important 
implications on the search for treatments as well as on clinical practice, as therapies may 
need to be tailored to the distinctive biological features of each patient subset. Thus, the 
generation and phenotyping of dozens of zebrafish models of ASD will offer insights not 
only into core aspects shared across all the models but will also be a powerful tool for the 
analysis of the pleiotropic features of ASD biology. 
Tailoring therapies to particular forms of ASD will require identification of drugs 
that act through molecular mechanisms potentially unique to the ASD subset targeted.  
Drug screening is a labor intensive and time consuming process.  A possible short cut that 
may save time and effort is to focus on small molecules already “prescreened” by nature.  
The following section discusses this approach with a focus on anxiety and epilepsy 
related efficacy.  
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4. Screening of natural products using zebrafish behavior: epilepsy and anxiety 
4.1 Drug discovery and Zebrafish 
Conventional drug discovery schemes focus on: (a) target discovery and 
validation; (b) screening hits-to-leads libraries; and (c) lead optimization of 
pharmacological and toxicological properties.  In addition, the extremely high failure rate 
of many preclinical drug candidates is attributed in part to their undesirable 
pharmacological or toxicological properties. Zebrafish are well-suited for high 
throughput screening for small molecules and genetic mutations generated, for example, 
by the increasingly powerful Crispr/Cas9 system. Zebrafish-based high throughput 
screening has been suggested by many authors, but remains underutilized for CNS drugs 
despite that phenotypic screening using these fish may aid drug discovery. As previously 
mentioned, the ease of maintenance and breeding of zebrafish, and their similarities to 
rodents render these fish amenable for behavioral screens.  Moreover, many of the 
behavioral tests used in rats are easily adapted to zebrafish (Kalueff et al., 2014), making 
them ideal to study human disorders. For example, zebrafish mutants have been identified 
even for rare human disorders, including Dravet syndrome (heritable form of pediatric 
epilepsy), and they have been utilized in screening for approved drugs to find possible 
treatments for such disorders (Baraban el al, 2013, Dinday and Baraban, 2015). 
 
4.2 Natural products  
The use of drugs obtained from nature is not new.  At least 25 % of the drugs 
employed currently in the human clinic have been derived from natural products 
Zebrafish models of human brain disorders 27 Shams et al. 
 
(Newman and Cragg 2012, Cragg and Newman 2013). However, screening natural 
products for specific biological properties is a daunting task, as one often has to start with 
a complex mixture of unknown compounds, a problem that may be resolved with 
purification. The combination of purification and zebrafish-based screening has already 
been successfully employed (Bohni et al., 2013; Brillatz et al. 2016; Challal et al., 2014; 
Crawford et al., 2014; Tabassum et al., 2015). 
A significant number of people consume natural supplements without validation of 
the effectiveness of the active ingredients of these supplements and without a concern for 
their safety or possible interactions with conventional (e.g. FDA approved) drugs. Thus, 
it is important to characterize such natural supplements and identify their active 
ingredients, which later could be tested under controlled conditions in preclinical as well 
as human trials. The need for such efforts is clear, given that conventional drugs have 
often been found ineffective, or difficult to develop. There are pharmacological 
treatments for epilepsy and for anxiety, however, the efficacy of pharmacotherapy is 
suboptimal. Approximately 30 % of patients do not respond well to conventional 
anticonvulsants or develop resistance to such drugs (Lazarowski et al., 2015). In addition, 
epileptic patients have a higher incidence of comorbidity of depression and anxiety 
(Tellez-Zenteno et al., 2007), further highlighting the need to develop safer therapeutic 
compounds that may be able to target the complex interactions of concurrent conditions.    
Ethnopharmacology-based screening may result in faster and cheaper identification 
and optimization of active ingredients. In this section, a few examples will focus on 
discoveries in one author’s lab (Ortiz), who has used zebrafish to test extracts from 
Valeriana officinalis and Citrus aurantium for potential anticonvulsant and anxiolytic 
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activity and have utilized the zebrafish to identify possible mechanisms underlying the 
effect of these extracts. 
 
4.3 Anxiety screening 
Two behavioral paradigms sensitive to detect anxiety-like responses in the 
zebrafish, the open field and the light-dark preference test, have been used to investigate 
the effects of natural products and other small molecules.  These behavioral tests are 
direct adaptations from tests originally developed for laboratory rodents. In the light-dark 
preference task the anti-epileptic and anxiolytic compound, clonazepam, has been found 
to increase the time spent in the light side, while caffeine, a stimulant, markedly reduced 
this response (del Valle-Mojica and Ortiz, 2012).  The fish were tested in groups 
(typically 3 fish at a time) because their behavior is less variable in such setting (del 
Valle-Mojica and Ortiz, 2012) (also se figure 1).   
 
Valeriana officinalis 
Valerian (Valeriana officinalis) is a perennial flowering plant native to Europe and 
parts of Asia, and also introduced to North America, and is used as an herbal supplement.  
Different formulations of valerian roots are sold to reduce anxiety (anxiolytic) or as a 
sleep aid [http://ods.od.nih.gov/pdf/factsheets/Valerian-HealthProfessional.pdf].  The 
Ortiz laboratory has found that aqueous valerian extract and valerenic acid (a marker 
compound of V. officinalis) both increased the time zebrafish spend in the light side in the 
light dark preference task, similarly to clonazepam (del Valle-Mojica and Ortiz, 2012). 
Furthermore, studies have identified interactions of valerian extracts with the 
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metabotropic glutamate receptors, mGluR I and mGluR II receptors in vitro (Del Valle-
Mojica et al., 2011) and in adult zebrafish (del Valle-Mojica and Ortiz, 2012). 
 
Citrus aurantium 
Sour orange (Citrus aurantium) is a tree native to southeast Asia, but it has been 
spread by humans to many other parts of the world. The peel of the Citrus aurantium’s 
fruit is often used as weight loss supplement, as a replacement for ephedra (Haaz et al., 
2010).  Notably, Citrus aurantium leaf extracts are also used to treat anxiety in Puerto 
Rican folklore medicine and in other cultures (Alvarado-Guzmán, 2009, Hernandez et al., 
1984; Pimenta et al., 2016).  Aqueous extracts devoid of the sympathomimetic 
compounds present in the fruits’ peel (Rosa-Falero et al., 2015), exert anxiolytic effects 
in zebrafish in both the open field and the light-dark preference tasks (Ortiz, unpublished 
results, also see figure 2).  In vitro, Citrus aurantium interacts with all GluRs (Rosa-
Falero et al., 2015).  Citrus aurantium extracts also display a “U” shaped dose response 
that has been difficult to analyze (Ortiz, unpublished results). 
 
4.4 Anticonvulsant screening 
Baraban et al. (2005) pioneered the use of pentylenetetrazol (PTZ) to induce 
seizures in the zebrafish.  This method has been adapted to screen extracts with potential 
anticonvulsant properties (Torres-Hernandez et al., 2015, Rosa-Falero et al., 2015). 
 
Valeriana officinalis 
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Valeriana officinalis and valerenic acid have anticonvulsant properties in adult 
zebrafish (Torres-Hernandez et al., 2015).  Moreover, valerian extracts potentiate the 
anticonvulsant effects of clonazepam and of phenytoin.  Adenosine (A1) receptors and 
group I and II metabotropic glutamate receptors (mGluRs) interact with the effect of 
valerian, and alter the onset of PTZ-induced convulsions (Torres-Hernandesz et al., 2015; 
2016). For example, antagonist for adenosine A2 receptors and group III mGluRs have 
been found to significantly reduce the effect of  valerian (Torres-Hernandesz et al., 2015; 
2016). Last, the effects of valerian extract were reduced by pre-treatment with selective 
antagonists for GABAA, AMPA and KA (ionotropic glutamate receptors), and for group 
II mGluRs receptors. (Torres-Hernandez et al., submitted). 
In larval zebrafish, Valeriana officinalis and valerenic acid have been found to 
reverse PTZ-induced alterations in swimming behavior (Torres-Hernandez et al., 2016).  
Moreover, the effects of PTZ on the immediate early genes c-fos, bdnf, and npas4 genes 
have been found to be reversed by Valeriana officinalis and valerenic acid (Torres-
Hernandez et al., 2016). 
 
Citrus aurantium  
Citrus aurantium's extracts are used in Puerto Rico and other cultures in folklore 
medicine to treat anxiety (Alvarado-Guzmán 2009; Hernandez et al., 1984; Pimenta et al., 
2016). An aqueous extract made from C. aurantium’s leaves has anticonvulsant 
properties in a PTZ-induced seizure model of zebrafish (Rosa-Falero et al., 2014).  
Preliminary results (Ortiz unpublished) suggest that NMDA- receptors and mGluRs I and 
II may mediate the anticonvulsant effects of Citrus aurantium.  Moreover, Citrus 
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aurantium extracts potentiate the anticonvulsant effects of phenytoin and of valproic acid 
(Rosa-Falero et al. unpublished results).  Activity-guided screening using zebrafish of 
different fractions (subsets of small molecules fractionated based upon biochemical 
properties) is currently being pursued in an attempt to refine the molecules involved. 
 
4.5 Future Prospects for Natural Product Screening in Zebrafish  
The above discussed studies demonstrate that V. officinalis and C. aurantium 
extracts have anticonvulsant and anxiolytic properties.  In addition, although the specific 
active ingredients of the extracts are awaiting confirmation, some mechanisms mediating 
these effects, notably mGluRs, have already been indicated.  It appears that the zebrafish 
will be a useful laboratory animal for the identification of psychoactive compounds from 
natural extracts.  First, zebrafish behavioral phenotypical screening may allow one to 
identify biological activity of complex extracts without having to know in advance what 
brain areas, brain functions, and what molecular mechanisms are affected.  Once such 
activity is found, identification of the active ingredients or the combination of active 
ingredients may require thorough and time consuming fractionation and chemical 
composition analyses, which again may be conducted more cheaply and efficiently with 
the zebrafish.   
Anxiety and epilepsy are but two of many central nervous system disorders one 
may be able to model using the zebrafish.  Modeling most human disorders, however, is 
often problematic because we often do not know the cause of the disease.  This is not an 
issue for the disorder cluster, the Fetal Alcohol Spectrum Disorders (FASD), discussed in 
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the subsequent section.  These diseases are clearly caused by alcohol consumed during 
pregnancy. 
 
5. Developing a zebrafish model of milder forms of FASD 
Modeling human diseases with the use of laboratory organisms has several 
advantages compared to studying the disease directly in humans.  These include better 
laboratory control of known factors that affect the disease under study, better 
experimental techniques available for manipulation of the biological mechanisms 
suspected to underlie the disease, and also importantly reduced cost and increased 
efficiency of research. As the previous sections have already demonstrated, all of these 
advantages characterize research with the zebrafish. Using animals to study alcohol 
related human disorders has yet another advantage compared to models of many other 
disorders: the cause of the disease (alcohol exposure) is known. 
 
5.1 What is FASD? Symptoms, prevalence and treatment options 
FASD encompass a cluster of diseases with differing severity and varied 
symptomatology (Nash et al., 2006; 2008; Streissguth et al., 1978). The common 
underlying feature of these diseases is their cause: alcohol consumption during 
pregnancy. Although these diseases could be completely eradicated by not drinking 
alcohol, fetal alcohol exposure remains the single most frequent cause of intellectual 
disability in children (Mattson et al., 2011; Stratton et al., 1996). The prevalence of 
FASD is estimated to range from 1 to in 5% in the Western world (Sampson et al., 1997; 
May et al., 2009), an alarmingly large number given the known deleterious effects of 
alcohol on the fetus. The severity or type of symptoms within FASD define different 
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subsets or categories of the disorder (Stratton et al., 1996). The most severe form of the 
disease is Fetal Alcohol Syndrome (FAS), which is often characterized by clearly 
observable anatomical, for example, facial abnormalities, growth retardation and 
significant impairment in executive function, learning and memory, language, visual-
spatial ability, motor function, and attention (Stratton et al., 1996; Mattson et al., 2011). 
Milder forms of the disease have different diagnostic names, for example, alcohol related 
neurological disorder (or ARND), but common to all of them is the lack of gross 
anatomical changes (Stratton et al., 1996). These disorders may be milder, but patients 
suffering from them do exhibit numerous behavioral impairments, including cognitive 
impairment. Abnormal social behavior is more recently recognized as one of the 
hallmarks of the milder forms of FASD (Stevens et al., 2015). These abnormalities may 
manifest as reduced empathy and perspective taking, decreased ability to solve social 
problems, and difficulty interpreting mental states and emotions of others (Greenbaum et 
al., 2009; Stevens et al., 2015). Despite the high prevalence of FASD and the life-long 
adversity faced by patients suffering from this disease, no treatment is available, and even 
clear diagnostic criteria, such as testable biomarkers, are absent. To address these serious 
issues, numerous animal models have been proposed, zebrafish being one of the newest, 
but perhaps most powerful, among them (Gerlai, 2015; Patten et al., 2014). 
 
5.2 Zebrafish models of FASD 
In addition to the advantages of the zebrafish as a biomedical research organism 
discussed in the introduction, it is also an ideal model organism for the analysis of 
alcohol effects in general, and for the analysis of the effects of alcohol on the developing 
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embryo in particular. The eggs of zebrafish are externally fertilized, develop outside the 
mother and without her influence. This was a major advantage for developmental 
biologists who could view the development of the embryo under the microscope without 
having to employ invasive methods. This is also a major advantage from the perspective 
of neuroscientists interested in modeling FASD. The eggs and the embryos inside may be 
exposed to alcohol at any specific desired stage of development for precisely preset 
periods of time and at specific experimentally determined doses (Fernandes and Gerlai, 
2009). This level of experimental control cannot be achieved in mammalian systems. 
This feature may be viewed as a disadvantage, as it does not realistically mimic what 
happens in case of mammalian embryos, which develop in the uterus and are protected by 
numerous defense mechanisms of their mother. However, the fish model may also be 
viewed as having advantages over mammalian (e.g. rat or mouse) models exactly because 
it is devoid of the complications associated with maternal physiology and maternal care 
(Fernandes and Gerlai, 2009). It is a simplistic and reductionist model that seeks to 
address the questions of how alcohol affects the development of the embryonic brain and 
how this alteration may manifest in behavior later in life. 
 
5.3 A realistic zebrafish model of the most prevalent, milder, forms of the disease 
Recognizing the above advantages of zebrafish, this species was first utilized in 
modeling FAS, the most severe forms of FASD. Zebrafish embryos exposed to high 
doses of alcohol (1.5-2.9% vol/vol alcohol) for prolonged periods of time (from several 
hours to days) indeed developed robust anatomical abnormalities including 
microphthalmia, heart defects, enlarged body cavities, increased mortality (Arenzana et 
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al., 2006; Bilotta et al., 2004; Carvan III et al., 2004). These early zebrafish FASD 
models were highly useful as they provided clear experimental evidence that alcohol 
affects the developing embryo even in fish, and the resulting anatomical abnormalities 
mimic many of the features seen in the severe forms of the disease in humans. 
However, these early zebrafish models did not mimic what happens in the most 
prevalent forms of the disease, the milder cases of FASD. The milder forms of FASD are 
likely the result of exposure to lower level and less frequent consumption of alcohol.  
Fernandes and Gerlai (2009) tried to mimic this alcohol exposure by administering small 
doses (up to 1%, vol/vol % bath concentration) of alcohol for only a short period (2 
hours) to eggs of zebrafish at their 24th hpf stage. This study importantly also analyzed 
how much alcohol actually reached the embryo inside the egg (the chorion, the eggshell, 
is protective), and found that depending on dose, about 1/25th to 1/30th of the external 
bath concentration of alcohol could be detected inside the egg. That is, in case of 1% 
external bath concentration, 0.04% alcohol reached the embryo (Fernandes and Gerlai, 
2009). Considering the North American legal limit of blood alcohol concentration for 
driving being 0.08%, the above value is within a “physiological”, range, at least as 
compared to typical human exposures. 
 
5.4 Behavioral effects of exposure to low concentration of alcohol during embryonic 
development in zebrafish 
Zebrafish exposed to alcohol at 24 hpf for 2 hours at external bath concentrations up 
to 1% (vol/vol) survived the treatment without any obvious signs of abnormality. These 
fish grew with the same rate as their control counterparts, appeared to move normally, 
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and their physical appearance was also of a typical wild type healthy zebrafish.  Detailed 
analysis of their motor function also did not reveal any defects (Fernandes and Gerlai, 
2009). However, when tested for their responses to social stimuli (images of moving 
conspecifics, described earlier), the alcohol exposed fish showed a significant 
impairment. Upon the presentation of these images, normal control fish approached the 
images and stayed in close proximity of the images. However, alcohol exposed fish 
stayed significantly farther from the images (Fernandes and Gerlai, 2009). It is important 
to emphasize that the impairment was found in adult, about 6 months old, fully 
developed, sexually mature zebrafish.  In fact, subsequent studies demonstrated that the 
impairment persisted in much older (2 years old) zebrafish, as well (Fernandes et al., 
2015a). Importantly, this behavioral impairment was found highly dose dependent (figure 
3A). At the lowest employed dose (0.25% alcohol, vol/vol) the impairment was 
significant but only modest, but at the highest dose (1.00% alcohol, vol/vol), the 
impairment was severe. In fact, fish exposed to the highest alcohol concentration during 
their embryonic development did not respond to the conspecific images at all when tested 
at their adult stage; that is, the distance they maintained from the image presentation 
screen during image presentation was statistically indistinguishable from the distance 
they kept from the screen before the presentation begin. Bathing the eggs in 1% alcohol 
for 2 hours at 24 hpf abolished the response to conspecific images in the adult fish 
(Fernandes and Gerlai, 2009).   
What could be behind this impairment? There may be many reasons the alcohol 
exposed fish did not properly shoal. One possibility is that they were unable to perform 
the appropriate motor responses due to impaired motor function. This working hypothesis 
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turned out to be incorrect as analysis of the movement patterns of the embryonic alcohol 
exposed fish revealed no abnormalities (Fernandes and Gerlai, 2009). The general 
activity of the alcohol exposed fish, as measured by distance swum, was statistically 
indistinguishable from that of control fish. Similarly, the top speed, the number of fast 
and slow swim episodes, the number and degree and direction of turning performed by 
the alcohol exposed fish were statistically indistinguishable from the behavior of control 
fish. Another possible reason why the alcohol exposed fish showed impaired shoaling 
could be compromised vision, possibly from alcohol exposure during ontogenesis 
disrupting the development of the eye or other parts of the visual system. However, this 
working hypothesis was also found unlikely. The direct evidence against it came from the 
study performed by Fernandes and Gerlai (2009), who found that moving images of 
conspecifics elicited two distinct behavioral responses in healthy normal zebrafish: one, 
the classic shoaling response (staying close to the images); and two, reduction of 
swimming activity, i.e. slowing down.  Interestingly, the latter response remained 
unaffected in embryonic alcohol exposed fish (Fernandes and Gerlai, 2009). That is, 
although these fish suffered from a significant impairment in their shoaling response, 
they reduced their swim speed and general activity upon presentation of the animated 
conspecific images just like control fish did. The latter response is only possible if the 
alcohol exposed fish could see the images. The indirect evidence for vision not 
explaining the reduced shoaling response came from a study that investigated freely 
moving shoals of zebrafish. Buske and Gerlai (2011) exposed zebrafish to alcohol during 
their embryonic development in the same manner as was employed in the Fernandes and 
Gerlai (2009) study but investigated the effect of the manipulation in freely moving 
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zebrafish tested in a large open tank. In this set up too, embryonic alcohol exposed 
zebrafish were found to exhibit impaired shoaling as measured by a farther swimming 
distance between each other compared to control fish. Given that blind cave tetras as well 
as experimentally blinded shoaling fish of other species have been demonstrated to shoal 
normally (Gregson and Burt de Perera, 2007; Partridge and Pitcher, 1980), the role of 
visual impairment underlying the observed embryonic alcohol induced changes in 
shoaling seems unlikely (Buske and Gerlai, 2011). The third possibility that may explain 
the observed embryonic alcohol exposure induced impairment of shoaling responses we 
considered is altered fear and/or anxiety.  One of the main adaptive functions of shoaling 
is believed to be predator avoidance, as more fish in a group may be able to detect an 
approaching predator sooner (Pitcher, 1993). Additionally, selecting a single target 
among many moving targets may be more difficult for the predator (Krause and Ruxton, 
2002). Irrespective of what may be the actual function of shoaling, however, it has been 
shown to increase under aversive conditions.  For example, the inter-individual distance 
among shoal members decrease in novel environments (mildly aversive context) and 
increase once the fish are habituated (Miller and Gerlai, 2007; Speedie and Gerlai, 2008). 
A fast-approaching predator triggers a rapid escape response (dispersal of the shoal) 
followed by a tightening of shoal cohesion (reduction of inter-individual distance among 
shoal members). Thus, it is possible that the impaired shoaling response observed in 
embryonic alcohol exposed zebrafish was the result of altered (reduced or enhanced) fear 
and/or anxiety in these fish.  However, this working hypothesis also turned out to be 
incorrect. Seguin et al., (2016) found that zebrafish exposed to alcohol in the same 
manner, at the same developmental stage and with the same concentrations and exposure 
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period as conducted by Fernandes and Gerlai (2009), exhibited no alterations under 
aversive conditions or in response to the appearance of a moving image of a sympatric 
fish predator. What could explain the abnormal responses to social stimuli then? 
There are two remaining possibilities to consider. First, zebrafish exposed to alcohol 
during embryonic development may not recognize their conspecifics as such, and thus do 
not want to shoal with them. This hypothesis remains untested, although it appears 
unlikely to be correct.  In nature, zebrafish form mix species shoals, mingling with fish of 
others species that have similar body size and general shape (Engeszer et al., 2007). In 
the laboratory too, these fish show shoaling responses towards animated fish images 
whose features differ from those of conspecifics (Saverino and Gerlai, 2008). The second 
possibility is that for some reason, although the embryonic alcohol treated zebrafish do 
recognize the images (or their conspecific shoal members) as appropriate shoal mates, 
their motivation to join the shoal is diminished. The dopaminergic system is known to be 
involved in reward.  Could the dopaminergic system be impaired in embryonic alcohol 
exposed zebrafish? 
 
5.5 Potential mechanisms underlying embryonic alcohol exposure induced 
behavioral abnormalities in zebrafish 
Alcohol is known to interact with a large number of molecular targets and in a 
concentration and exposure regimen dependent manner. Exposure to alcohol during 
embryonic development may lead to an even more complex effect profile, given that the 
initial alcohol induced changes may be followed by an avalanche of subsequently 
modified secondary responses. Given the expected complexity of such changes, one may 
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need to conduct a comprehensive analysis of gene expression changes using deep-
sequencing technologies or more traditional DNA microarrays, a drug screen to test for 
compounds that may alter the embryonic alcohol induced changes, or a genetic screen to 
identify mutated genes that may exacerbate, diminish or negate the embryonic alcohol 
induced changes, to mention but a few approaches one could take. However, such 
comprehensive analyses are expensive and time consuming. Instead, as a first step, a 
hypothesis driven proof of concept analysis was conducted to test whether the 
dopaminergic system of the embryonic alcohol exposed fish have been altered.  The 
rationale for this choice was supported by multiple findings. First, the sight of 
conspecifics was found to be rewarding; specifically, the presentation of live stimulus 
fish was demonstrated to serve as an unconditioned stimulus (reinforcement) in a 
classical conditioning paradigm (Al-Imari and Gerlai, 2008). Second, using a dopamine 
D1-receptor antagonist Scerbina et al. (2012) have been able to impair (reduce or abolish) 
shoaling, an effect that was concentration dependent. Third, and perhaps most 
importantly, Saif et al. (2013) found that the appearance of conspecific images to induce 
an increase of the levels of dopamine and DOPAC (dopamine’s metabolite) in the 
zebrafish brain. 
For the above reasons, Gerlai and his colleagues decided to measure levels of 
dopamine and DOPAC in embryonic alcohol exposed fish. Using HPLC (high-precision 
liquid chromatography) specifically developed for the detection of neurochemicals in 
zebrafish (Chatterjee and Gerlai, 2009), the amount of dopamine and DOPAC was 
analyzed from whole brain extracts of zebrafish. Zebrafish from age 15 to 102 dpf were 
tested, and the relative amount of dopamine and DOPAC was found to significantly 
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increase as the fish developed (Mahabir et al., 2013). Importantly, however, this age-
dependent maturation of the dopaminergic system was significantly blunted or arrested in 
fish exposed to alcohol during their embryonic development. In other words, a significant 
linear alcohol concentration dependent effect was demonstrated, with lower doses having 
a milder (yet still significant) and the higher doses more robust effect (Mahabir et al., 
2013). Interestingly, further analysis revealed that basal levels of dopamine or DOPAC 
were unaltered by embryonic alcohol treatment. Fish that were housed alone and kept 
unstimulated by social cues exhibited similar levels of dopamine and DOPAC 
irrespective of whether they were alcohol treated or control (Fernandes et al., 2015b).  
However, and importantly, upon delivery of a social stimulus, control fish responded 
with a robust and significant increase of dopamine and DOPAC levels, while those fish 
that were exposed to alcohol during their embryonic development did not (Fernandes et 
al., 2015b) (figure 3B). These results thus confirm that embryonic alcohol exposure 
disrupts the ability of zebrafish to properly respond to social stimuli both at the level of 
dopaminergic neurochemistry and also at the level of behavior (shoaling). The finding of 
unaltered basal dopamine and DOPAC levels imply that dopamine production and release 
were unaltered in the embryonic alcohol exposed fish. Thus, one could speculate that the 
number of dopaminergic neurons and the structural integrity of the dopaminergic system 
in general may be intact in the alcohol exposed fish.  
The dopaminergic system in the zebrafish brain is relatively well explored. For 
instance, dopaminergic neurons have been identified in subpallial regions (Tay et al., 
2011) and in the periventricular nucleus of the posterior tuberculum of the zebrafish brain 
(basal diencephalon), a teleost dopaminergic system ascending to the subpallium 
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equivalent to the mammalian striatum (Rink and Wullimann, 2001). The connectome, 
that is, both the outputs (target areas) and the inputs (neurons connecting to dopaminergic 
neurons) of the dopaminergic system involve numerous neurotransmitter systems in 
several areas of the zebrafish brain (Tay et al., 2011). It is thus possible that although the 
dopaminergic neurons themselves may be intact, the development of their connectome is 
altered by embryonic alcohol exposure, and this alteration may explain the unresponsive 
nature of dopaminergic neurons to social stimuli. The intact nature of dopaminergic 
neurons and the possibility of abnormal ascending inputs to these neurons are also 
supported indirectly by finding unaltered motivation of embryonic alcohol exposed 
zebrafish to seek and obtain food in an associative learning task (Fernandes et al., 2014). 
What exactly may underlie the altered dopaminergic response, how and where the 
connectome of these neurons may have been altered, which neurotransmitter systems and 
brain areas are involved, and what molecular mechanisms underlie these changes, will 
need to be investigated in the future. 
 
5.6 Prospects for modelling FASD in zebrafish 
Building an animal model of a human disease has an inherent paradox. In order for one to 
properly model a human disease, one has to understand the mechanisms of the disease. 
But most often the very reason why one would want to create an animal model is to 
investigate these mechanisms. The mild fetal alcohol spectrum disorder model with 
zebrafish described above suffers from the same problem. This model, as all animal 
models of human diseases, needs to meet three primary criteria: face, construct and 
predictive validity. The zebrafish FASD model arguably meets the face validity criterion. 
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That is, the phenotypical features, or the appearance of symptoms, seen in zebrafish 
exposed to alcohol during embryonic development are similar to those seen in human 
FASD cases. For example, high alcohol doses applied for a prolonged period of time 
during development induce anatomical malformations resembling those seen in the 
severe FAS cases, and lower concentrations of alcohol employed for short period of time 
also lead to changes at the level of behavior found typical in milder FASD cases. 
Construct validity of the zebrafish model, however, has not been established. Although 
the causal factor, alcohol, underlying the changes observed in humans and zebrafish is 
the same, and although the dopaminergic system has been implicated in FASD (see 
similarities of findings in rodent and primate studies and the zebrafish results reviewed 
by Schneider et al., 2011), the mechanisms underlying the observed behavioral and 
neurochemical changes seen in zebrafish have not been systematically explored, and any 
biomarkers that may be similar across mammalian and fish species have not been 
established.  Similarly, predictive validity, i.e. the question of whether the zebrafish 
model would respond to pharmacotherapy or other therapeutic approaches similarly to a 
human FASD patient will need to be assessed in the future. Clearly, the zebrafish FASD 
model is in its early building phase.  Nevertheless, given the high translational relevance 
of the zebrafish established in multiple zebrafish models of human diseases (see review 
by Pickart and Klee, 2014), the promising results already obtained with the zebrafish 
FASD model, the sophisticated molecular biology, neurobiology and more recently 
behavioral tools developed for this species, coupled with the relatively low cost typical of 
zebrafish research, we hope that the zebrafish FASD model will significantly contribute 
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to the understanding of the mechanisms, the diagnosis and the treatment of this life long-
disease. 
 
6. The zebrafish is a promising tool. But there are many shortcomings of this species 
we need to overcome. 
This review sampled highly different zebrafish research areas.  Common to all of 
them is the focus on the central nervous system and the use of behavioral methods. The 
advantage of behavioral tests over many other methods is that they allow the probing of 
the brain without having any preconceived notion of exactly what and where 
experimental manipulation induced modifications will occur. Indeed, behavioral tools 
have been successfully employed in a wide variety of research studies whose goal was to 
characterize or identify the experimentally induced functional change in the CNS, be it a 
genetic manipulation or a pharmacological agent or a neuroanatomical method such as 
lesioning. Although the past decade has seen a dramatic upsurge in studies of zebrafish 
employing behavioral methods (Kalueff et al., 2014), the number of behavioral tests 
developed for and the depth of our understanding of the behavioral features of the 
zebrafish is still dwarfed by studies on more traditional laboratory rodents, the house 
mouse and the rat (Kalueff et al., 2014; Sison et al., 2014).  The behavioral bottle neck is 
a serious issue for zebrafish research, especially considering the dramatic development of 
molecular biology and the powerful recombinant DNA techniques developed for this 
species.  These methods now allow unprecedented precision with which one can discover 
novel genes (forward genetics) or manipulate known genes (reverse genetics).  Without 
proper behavioral tools, however, screening for mutation effects on brain function, or 
Zebrafish models of human brain disorders 45 Shams et al. 
 
characterization of the effects of a targeted mutation of a gene expressed in the brain of 
zebrafish is difficult.  Continued focus on the development of sophisticated behavioral 
paradigms and on detailed characterization of zebrafish behavior is warranted. 
Another and perhaps equally important problem with zebrafish that we have already 
mentioned in the introduction concerns pharmacology. With the increasingly 
sophisticated recombinant DNA technologies, the use of compounds and drugs in 
research has been diminishing. This is understandable because recombinant DNA 
techniques offer unprecedented precision with which a biological system may be 
manipulated, its biochemical reactions altered, mapped and functionally characterized. In 
addition to being used as a research tool, recombinant DNA technologies now also offer 
therapeutic possibilities, such as the increasingly powerful gene therapy and/or 
recombinant protein-based methods. However, pharmacotherapy still represents an 
overwhelmingly dominant part of available therapeutic methods for countless human 
diseases.  It is unlikely this will dramatically change in the near future. Pills will likely 
remain one of the most frequently used methods to treat people. Thus, 
psychopharmacology will remain an important field for translational or medical research 
and treatment development.  Unfortunately, however, psychopharmacology of the 
zebrafish is a highly underexplored research area. The pharmacological characterization 
of compounds, small molecules with biological activity, is often completely lacking for 
the zebrafish. Although numerous studies, some of them reviewed above, have 
demonstrated evolutionary conservation of the effects of a range of drugs and compounds 
from fish to mammals, detailed pharmacological characterization of the compounds 
employed with zebrafish is rarely performed. Unlike for rodents, zebrafish researchers 
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usually have little idea about ADME characteristics of the compound they are using. 
Receptor occupancy studies are also rarely available for zebrafish. The limited amount, or 
complete absence, of such information represents a significant bottleneck in zebrafish 
research. 
 
7. Overall outlook and summary 
This review focused on the use of the zebrafish in behavioral neuroscience and 
psychopharmacology research. Although the growth of studies with zebrafish in these 
research areas has been exponential, compared to the rat or the house mouse, the 
zebrafish is still a relative newcomer. Why should any experimenter use it then?  There 
are numerous specific reasons, some of which we have discussed in this review, others 
have been emphasized elsewhere in the literature (Chen & Ekker, 2004; Conant & Wolfe, 
2008; Gerlai, 2010; 2012; 2015; Kalueff et al., 2014; Levin et al., 2015; Morris, 2009; 
Patton & Zon, 2001; Pickart & Klee, 2014; Rihel & Schier, 2012; Sison et al., 2006; 
Stewart et al., 2015a; 2014). From its practical advantages, low cost and simplicity, 
through the ease with which it may be manipulated using a variety of tools, to its 
translational relevance, many of the features of the zebrafish suggest that this small fish 
will continue to make waves in research. Although comparing advantages and 
disadvantages of particular research organisms is a useful exercise, perhaps an additional 
point should also be reemphasized here. Even if the zebrafish is inferior in some respects 
to other model organisms (e.g. consider its relative novice status and the bottleneck this 
may represent for certain research methods or approaches), adding it to research enhances 
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translational relevance because it allows us to discover and focus on evolutionarily 
conserved, fundamental aspects of the studied phenomena (Gerlai, 2014). 
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FIGURE LEGENDS 
Figure 1.  Group vs Individual testing.  Adult zebrafish prefer to move in groups 
(shoaling).  In these experiments, animals were tested in groups (3 fish/group) and 
retested as individuals half hour later. One hour after being regrouped, there is still 
considerable dispersion in the time spent in the light area.   
Figure 2.  Anxiolytic Effects of aqueous Citrus auratium extract on zebrafish in the light-
dark preference task.  (Del Valle-Mojica and Ortiz, 2012). Zebrafish were tested in the 
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light-dark test before (naïve) and after a one-hour long exposure to 20mg/mL extract 
for one hour.  
Figure 3. Behavioral and neurochemical changes in adult zebrafish induced by embryonic 
alcohol exposure.  Panel A shows the reduction of distance elicited by the presentation 
of moving (animated) images of conspecifics (zebrafish).  Mean + S.E.M. are shown 
The larger negative values represent more robust reduction.  Note that control (alcohol 
unexposed) zebrafish reduced their distance to the stimulus by 16 cm on average, but 
the response of zebrafish exposed previously to 1% alcohol is statistically 
indistinguishable from chance (i.e. no response to conspecific images).  Also note the 
quasi-linear dose response relationship between behavioral response and alcohol 
concentration.  Panel B shows the amount of dopamine relative to total protein weight 
as measured by HPLC from whole brain extract.  Mean + S.E.M. are shown.  The 
pairs of bars represent behavioral performance of fish exposed to alcohol at different 
concentrations (representing Vol/Vol%) of alcohol during embryonic development.  
The first bar in each pair shows the relative dopamine amount before conspecific 
images are shown.  The second bar shows the relative dopamine amount right after the 
conspecific images were shown.  Note the robust increase of dopamine in response to 
the images in control fish.  Also note the complete absence of this increase in alcohol 
exposed fish.  Modified from Fernandes and Gerlai (2009) and Fernandes et al., 
2015a) 
  
